Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Breast Neoplasms 68Neoplasms 32Prostatic Neoplasms 30Lung Neoplasms 24Head and Neck Neoplasms 20Neoplasm Metastasis 15Motor Activity 14Colorectal Neoplasms 14Multiple Myeloma 13Ovarian Neoplasms 11Gastrointestinal Neoplasms 11Fatigue 10Carcinoma, Non-Small-Cell Lung 10cyclopia sequence 8Uterine Cervical Neoplasms 8Pancreatic Neoplasms 8Pain 8Lymphoma 8Anxiety Disorders 8Smoking Cessation 7Recurrence 7Neoplasms, Plasma Cell 7Esophageal Neoplasms 7Endometrial Neoplasms 7Carcinoma, Renal Cell 7Tobacco Use Cessation 6Rectal Neoplasms 6Oropharyngeal Neoplasms 6Leukemia 6Depression 6

Interventions

Ifosfamide 30Methotrexate 27Doxorubicin 25Cyclophosphamide 24Cisplatin 22Filgrastim 18Etoposide 17Gemcitabine 16Leucovorin 14Magnetic Resonance Spectroscopy 11Temozolomide 10cabozantinib 9apatinib 9Specimen Handling 9Carboplatin 9fludarabine 8X-Rays 8Nivolumab 8Neoadjuvant Therapy 8Irinotecan 8Granulocyte Colony-Stimulating Factor 8Docetaxel 8Zoledronic Acid 7Vincristine 7Sirolimus 7Radiotherapy 7Phantoms, Imaging 7Biopsy 7Topotecan 6Mesna 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Osteosarcoma × Surveys and Questionnaires × Clear all
NCT03006848 2026-02-23

A Phase II Trial of Avelumab in Patients With Recurrent or Progressive Osteosarcoma

St. Jude Children's Research Hospital

Phase 2 Completed
19 enrolled 11 charts
Sarcoma

Osteosarcoma

NCT00673179 2014-09-10

Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy

M.D. Anderson Cancer Center

Phase NA Terminated
7 enrolled 3 charts
Sarcoma

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡